Page 2005 — Multidrug-resistant organism identification, contact precautions, room placement, environmental cleaning, and discontinuation criteria
Multidrug-resistant organisms (MDROs) are bacteria resistant to one or more classes of antimicrobial agents, usually including all but one or two commercially available drug classes. When a clinical microbiology lab reports an MDRO — MRSA, VRE, carbapenem-resistant Enterobacteriaceae (CRE), or a similarly resistant pathogen — the result is not just a treatment decision point. It automatically triggers infection-prevention protocols that shape how every subsequent caregiver interacts with the patient.
The CDC defines an MDRO broadly as a microorganism, predominantly bacteria, resistant to one or more classes of antimicrobial agents. In practice, infection-prevention programs track a defined watch-list:
• MRSA (methicillin-resistant Staphylococcus aureus) — resistant to all beta-lactams via altered PBP2a • VRE (vancomycin-resistant Enterococcus) — resistant to glycopeptides via altered cell-wall precursor targets • CRE (carbapenem-resistant Enterobacteriaceae) — resistant to carbapenems, often via KPC, NDM, or OXA-48 carbapenemases • ESBL-producing Enterobacteriaceae — extended-spectrum beta-lactamases hydrolyzing penicillins and cephalosporins • Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii • Clostridioides difficile — not classically "multidrug-resistant" in the antibiotic sense, but managed under the same contact-precaution framework because of its transmissibility and spore persistence
Each organism triggers a slightly different precaution profile, but all share the same starting event: a positive culture or PCR result flagged by the microbiology laboratory.
Modern hospital laboratory information systems are configured to auto-flag any organism on the MDRO watch-list the moment final identification and susceptibility results post. That flag does three things simultaneously:
1. Pushes a best-practice alert to the ordering clinician and bedside nursing staff 2. Auto-generates a contact-precaution order in the electronic health record 3. Notifies the infection-prevention team for surveillance and outbreak tracking
Because resistant organisms can be transmitted before the culture even results — often 24–72 hours after specimen collection for standard culture, faster for PCR-based rapid diagnostics — many hospitals apply presumptive precautions to high-risk patients (recent hospitalization abroad, known prior MDRO carriage, transfer from a facility with an active outbreak) while results are pending.
A positive MDRO culture is treated as a system event, not just a clinical data point — it simultaneously triggers PPE requirements at the doorway, room-placement review, and a future environmental-cleaning obligation at discharge, all from one lab result.
Contact precautions are the standard tier of isolation for most MDROs, designed to interrupt transmission by direct or indirect contact — hand-to-skin, hand-to-surface, or shared equipment. The protocol is deliberately simple so it can be followed reliably under time pressure: gown and gloves before entry, single-patient or disinfected equipment, and door signage that makes the requirement visible before anyone crosses the threshold.
Contact precautions target the dominant transmission route for most MDROs: hands and surfaces. The core elements are:
• Gown: worn over clothing for all substantial patient or environmental contact; removed and discarded before leaving the room • Gloves: worn for all patient contact and surface contact within the room; changed between soiled and clean tasks even within the same encounter • Hand hygiene: alcohol-based hand rub or soap-and-water immediately after glove removal — gloves reduce but do not eliminate the need for hand hygiene, since micro-tears and doffing contamination are common • Dedicated or single-use equipment: stethoscopes, blood pressure cuffs, and thermometers are ideally kept in the room; shared equipment (portable X-ray, wheelchairs) is disinfected with an EPA-registered agent immediately after use
The sequence matters: PPE is donned outside the room before entry and doffed inside or at the threshold before exit, so contamination never travels down the hallway.
Standardized door signage — typically a colored card specifying "Contact Precautions" and the required PPE — serves two functions: it reminds staff who enter routinely, and it stops ad-hoc entrants (consulting physicians, transport staff, family members) who have not seen the chart flag.
Signage design principles that improve compliance:
• Icon-based instructions (gown, gloves) rather than text alone, for language-independent recognition • Placement at eye level directly on or beside the door, not on the chart holder where it can be missed • A dedicated PPE cart or wall dispenser immediately outside the door so compliance requires no extra steps • Clear differentiation from higher-tier signage (airborne, droplet) so staff do not under- or over-protect
Studies of hand hygiene and PPE compliance consistently show that removing friction — placing gowns and gloves within arm's reach of the door — improves adherence more than signage alone. Contact precautions fail most often not from knowledge gaps but from access gaps.
Where a patient is physically placed is itself an infection-control intervention. A private room is the gold standard because it eliminates any shared airspace, bathroom, or bedside equipment with another patient. When private-room capacity is constrained, cohorting — grouping patients who carry the identical organism in the same room — preserves most of the protective effect, provided roommates are not immunocompromised or otherwise at elevated risk of severe infection.
A private room removes the two most common indirect transmission pathways: a shared bathroom (relevant for VRE and C. difficile, both shed heavily in stool) and shared bedside surfaces (bed rails, overbed tables, call buttons) that a roommate or their visitors might touch.
When private rooms are unavailable, facilities apply a placement hierarchy:
1. Private room with private bathroom — always first choice 2. Cohort with a patient carrying the same organism — acceptable when confirmed by culture or known epidemiologic link 3. Placement with a low-risk roommate, with enhanced spatial separation (curtain drawn, ≥3 feet between beds) — last resort, requires heightened surveillance
Cohorting decisions require confirming genuine organism identity, not just the same MDRO category — pairing two different CRE strains, for example, can create a new transmission opportunity rather than reducing risk.
Not every patient is an acceptable cohort partner even if they share the same organism. Infection-prevention teams weigh:
• Immunosuppression: transplant recipients, neutropenic oncology patients, and those on high-dose steroids face disproportionate harm from even low-inoculum exposure • Open wounds or indwelling devices: central lines, surgical wounds, and urinary catheters in a roommate create additional colonization entry points • Cognitive or mobility status: a confused or mobile roommate who cannot maintain precautions increases cross-contamination risk • Anticipated length of stay: short-stay patients are lower priority for the limited private-room supply than those requiring extended precautions
Placement is reassessed at every unit transfer, since a bed move resets the roommate-risk calculation entirely.
Cohorting is a resource-driven compromise, not a preference — the evidence base still favors single rooms whenever bed capacity allows, and cohorting decisions are documented and reviewed by infection prevention, not made ad hoc by bed management alone.
Once a patient carrying an MDRO is discharged or transferred, the room itself becomes the next control point. Terminal cleaning is intensified beyond routine daily cleaning, and the disinfectant chosen must match the organism's environmental resilience — a distinction that matters enormously for spore-forming organisms like Clostridioides difficile, which standard hospital disinfectants do not reliably kill.
Most MDROs — MRSA, VRE, CRE, ESBL producers — are vegetative bacteria killed effectively by standard EPA-registered hospital disinfectants (quaternary ammonium compounds, accelerated hydrogen peroxide, improved-efficacy phenolics). Routine terminal cleaning with one of these agents, applied to all high-touch surfaces (bed rails, call buttons, doorknobs, overbed table, bathroom fixtures), is sufficient.
Clostridioides difficile is the critical exception. C. diff forms metabolically dormant endospores that are resistant to alcohol, quaternary ammonium compounds, and many standard disinfectants. Spores can persist on dry hospital surfaces for weeks to months, and alcohol-based hand rub does not reliably kill them — soap-and-water hand washing with mechanical friction is required for hand hygiene, and a sporicidal agent (typically a 1:10 dilution of 5.25–6.15% sodium hypochlorite bleach, or an EPA List K product) is required for surface disinfection.
A properly intensified terminal clean includes:
• High-touch surface disinfection: bed rails, call button, IV pole, door handles, light switches, remote controls • Bathroom disinfection: toilet, sink, grab bars — proportionally higher risk for organisms shed in stool (VRE, CRE, C. diff) • Curtain replacement: privacy curtains are a frequently overlooked fomite and are changed, not just wiped • Contact time compliance: disinfectant must remain wet on the surface for the manufacturer-specified contact time (often 1–10 minutes) to achieve labeled kill claims — wiping dry early is a common compliance failure • Adjunct technologies: UV-C room disinfection or hydrogen-peroxide vapor systems are increasingly used as a supplement after manual cleaning, particularly for C. diff and CRE rooms, but do not replace manual cleaning of visibly soiled surfaces
Fluorescent-marker and ATP-bioluminescence audits of terminal cleaning consistently find that a meaningful fraction of high-touch surfaces are missed during routine cleaning — a key driver behind the adjunct-technology adoption for MDRO rooms, especially C. difficile.
Contact precautions are not indefinite. Each organism has its own discontinuation criteria, and applying them correctly matters in both directions: stopping too early risks onward transmission, while continuing unnecessarily consumes PPE, isolates patients psychosocially, and occupies private-room capacity needed for the next MDRO admission.
Because MDROs differ in how reliably colonization clears and how contagious they remain once symptoms resolve, discontinuation follows three distinct models:
1. Culture-based clearance (MRSA, VRE): precautions are lifted after a defined number of consecutive negative surveillance cultures — commonly two to three, collected days apart, ideally while the patient is off antimicrobial therapy that could suppress detection without eliminating carriage. False-negative single cultures are common, which is why repetition is required.
2. Time-based resolution (C. difficile): precautions typically continue through active diarrhea and for a defined period after symptoms resolve — commonly 48 hours — because spore shedding drops sharply once stool normalizes, even though a culture-based test would remain irrelevant (C. diff toxin testing is not repeated to "clear" a patient once treated).
3. Extended or admission-duration precautions (CRE and other highly resistant gram-negatives): because carbapenemase-producing organisms are epidemiologically high-consequence and colonization can persist for months, many institutions maintain precautions for the entire hospital stay regardless of clinical improvement, only reassessing at the next admission.
Once discontinuation criteria are met, the precaution order is discontinued in the EHR, but the MDRO history itself is never deleted — it remains a permanent flag on the patient record. On any future readmission, most protocols default to reinstating precautions at intake until current status can be reconfirmed, because colonization can silently persist or recur even after apparently successful clearance.
This creates an intentional asymmetry: it is easier and safer to over-flag a returning patient and de-escalate after confirmation than to under-flag and risk unrecognized transmission. The decision to discontinue, like the decision to place a patient in isolation in the first place, is a documented clinical judgment — not an automatic expiration.
Discontinuation is organism-specific by design: applying a single blanket rule (for example, "stop after 14 days" for every MDRO) would under-protect against CRE and over-restrict patients who cleared MRSA or VRE colonization weeks earlier.